Potential roles for infectious agents in the pathophysiology of primary biliary cirrhosis: What's new?

Current Infectious Disease Reports

Volumn 15, Issue 1, 2013, Pages 14-24

  Smyk, Daniel S ^a   Rigopoulou, Eirini I ^b   Bogdanos, Dimitrios P ^a,b,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^c Cellular Immunotherapy and Molecular Immunodiagnostics   (Greece)

Author keywords

Autoantibody; Autoimmune; Cholestasis; E. coli; Infection; Liver disease; Urinary tract infection; Viruses

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA VACCINE; TETANUS TOXOID; VIRUS PROTEIN;

ANTIBODY PRODUCTION; B LYMPHOCYTE; BACTERIUM; BETARETROVIRUS INFECTION; CAUSAL ATTRIBUTION; CD4+ T LYMPHOCYTE; CROSS REACTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE PREDISPOSITION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; ESCHERICHIA COLI; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IDD10 GENE; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; NONHUMAN; NOVOSPHINGOBIUM AROMATICUS; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PROTEIN EXPRESSION; RECURRENT INFECTION; REVIEW; RISK FACTOR; T LYMPHOCYTE; TOXOPLASMA GONDII; TOXOPLASMOSIS; URINARY TRACT INFECTION;

EID: 84873088352     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-012-0304-2     Document Type: Review

References (102)

1. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005;353:1261-73.
2. Lindor KD, Gershwin ME, Poupon R, et al. Primary biliary cirrhosis. Hepatology. 2009;50:291-308.
3. Smyk DS, Rigopoulou EI, Pares A, et al. Sex differences associated with primary biliary cirrhosis. Clin Dev Immunol. 2012;2012:610504.
4. Invernizzi P, Alessio MG, Smyk DS, et al. Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature. BMC Gastroenterol. 2012. in press.
5. Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol. 2012;56:1181-8.
6. Smyk D, Cholongitas E, Kriese S, et al. Primary biliary cirrhosis: family stories. Autoimmune Dis. 2011;2011:189585.
7. Jones DE, Watt FE, Metcalf JV, et al. Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol. 1999;30:402-7.
8. Kim WR, Lindor KD, Locke 3rd GR, et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology. 2000;119:1631-6.
9. Bogdanos DP, Komorowski L. Disease-specific autoantibodies in primary biliary cirrhosis. Clin Chim Acta. 2011;412:502-12.
10. Bogdanos DP, Baum H, Vergani D. Antimitochondrial and other autoantibodies. Clin Liver Dis. 2003;7:759-77. vi.
11. Bogdanos DP, Invernizzi P, Mackay IR, et al. Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol. 2008;14:3374-87.
12. Muratori L, Granito A, Muratori P, et al. Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value. Clin Liver Dis. 2008;12:261-76. vii.
13. Rigopoulou EI, Bogdanos DP, Liaskos C, et al. Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis. Clinica Chimica Acta Int J Clin Chemist. 2007;380:118-21.
14. Dahnrich C, Pares A, Caballeria L, et al. New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies. Clin Chem. 2009;55:978-85.
15. Bizzaro N, Covini G, Rosina F, et al. Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature. Clin Rev Allergy Immunol. 2012;42:288-97.
16. Bogdanos DP, Liaskos C, Rigopoulou EI, et al. Anti-mitochondrial antibodies in patients with systemic lupus erythematosus: revealing the unforeseen. Clin Chim Acta. 2006;373:183-4. author reply 5.
17. Metcalf JV, Mitchison HC, Palmer JM, et al. Natural history of early primary biliary cirrhosis. Lancet. 1996;348:1399-402.
18. Duarte-Rey C, Bogdanos D, Yang CY, et al. Primary biliary cirrhosis and the nuclear pore complex. Autoimmun Rev. 2012.
19. Itoh S, Ichida T, Yoshida T, et al. Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis. J Gastroenterol Hepatol. 1998;13:257-65.
20. Wesierska-Gadek J, Hohenauer H, Hitchman E, et al. Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-terminal domain of nuclear pore complex glycoprotein gp210. J Exp Med. 1995;182:1159-62.
21. Rigopoulou EI, Davies ET, Pares A, et al. Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut. 2005;54:528-32.
22. Bogdanos DP, Liaskos C, Pares A, et al. Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis. Hepatology. 2007;45:1583. author reply -4.
23. Mytilinaiou MG, Meyer W, Scheper T, et al. Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis. Clinica Chimica Acta Int J Clin Chemist. 2012;413:1211-6.
24. Liaskos C, Norman GL, Moulas A, et al. Prevalence of gastric parietal cell antibodies and intrinsic factor antibodies in primary biliary cirrhosis. Clinica Chimica Acta Int J Clin Chemist. 2010;411:411-5.
25. Muratori P, Muratori L, Guidi M, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol. 2003;132:473-6.
26. Rigopoulou EI, Roggenbuck D, Smyk DS, et al. Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found. Autoimmun Rev. 2012.
27. Wesierska-Gadek J, Penner E, Battezzati PM, et al. Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology. 2006;43:1135-44.
28. Rigamonti C, Bogdanos DP, Mytilinaiou MG, et al. Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges. Int J Rheumatol. 2011;2011:976427.
29. Bogdanos DP, Rigamonti C, Smyk D, et al. In: Radstake T, editor. Systemic sclerosis - an update on the aberrant immune system and clinical features. Rijeka, Croatia: Intech; 2012. p. 151-66.
30. Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology. 2000;31:1005-13.
31. Duarte-Rey C, Bogdanos DP, Leung PS, et al. IgM predominance in autoimmune disease: genetics and gender. Autoimmun Rev. 2012;11:A404-12.
32. Kikuchi K, Lian ZX, Yang GX, et al. Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology. 2005;128:304-12.
33. Bogdanos DP, Smyk DS, Rigopoulou EI, et al. Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun. 2012;38:J156-69.
34. Selmi C, Leung PS, Sherr DH, et al. Mechanisms of environmental influence on human autoimmunity: a national institute of environmental health sciences expert panel workshop. J Autoimmun. 2012.
35. Miller FW, Pollard KM, Parks CG, et al. Criteria for environmentally associated autoimmune diseases. J Autoimmun. 2012.
36. Smyk DS, Mytilinaiou MG, Milkiewicz P, et al. Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22. Autoimmun Highlights. 2012;3:1-9.
37. Smyk DS, Rigopoulou EI, Bizarro N, et al. Hair dyes as a risk for autoimmunity: from systemic lupus erythematosus to primary biliary cirrhosis. Autoimmun Highlights. 2012. in press.
38. Smyk D, Mytilinaiou MG, Rigopoulou EI, et al. PBC triggers in water reservoirs, coal mining areas and waste disposal sites: from Newcastle to New York. Dis Markers. 2010;29:337-44.
39. Smyk DS, Rigopoulou EI, Lleo A, et al. Immunopathogenesis of primary biliary cirrhosis: an old wives' tale. Immun Ageing. 2011;8:12.
40. Rigopoulou EI, Smyk DS, Matthews CE, et al. Epstein-barr virus as a trigger of autoimmune liver diseases. Adv Virol. 2012;2012:987471.
41. Smyk DS, Rigopoulou EI, Muratori L, et al. Smoking as a risk factor for autoimmune liver disease: what we can learn from primary biliary cirrhosis. Ann Hepatol. 2012;11:7-14.
42. Smyk DS, Bogdanos DP, Kriese S, et al. Urinary tract infection as a risk factor for autoimmune liver disease: from bench to bedside. Clin Res Hepatol Gastroenterol. 2012;36:110-21.
43. Smyk D, Rigopoulou EI, Baum H, et al. Autoimmunity and environment: am I at risk? Clin Rev Allergy Immunol. 2012;42:199-212.
44. Varyani FK, West J, Card TR. An increased risk of urinary tract infection precedes development of primary biliary cirrhosis. BMC Gastroenterol. 2011;11:95.
45. Smyk D, Rigopoulou EI, Yoh Z, et al. Infectious triggers of primary biliary cirrhosis: do we know enough? Curr Trends in Immunol. 2010;11:35-49.
46. Shigematsu H, Shimoda S, Nakamura M, et al. Fine specificity of T cells reactive to human PDC-E2 163-176 peptide, the immunodominant autoantigen in primary biliary cirrhosis: implications for molecular mimicry and cross-recognition among mitochondrial autoantigens. Hepatology. 2000;32:901-9.
47. Shimoda S, Nakamura M, Shigematsu H, et al. Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis. Hepatology. 2000;31:1212-6.
48. Shimoda S, Van de Water J, Ansari A, et al. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest. 1998;102:1831-40.
49. Bogdanos DP, Baum H, Gunsar F, et al. Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity. Scand J Gastroenterol. 2004;39:981-7.
50. Lan RY, Cheng C, Lian ZX, et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology. 2006;43:729-37.
51. Longhi MS, Ma Y, Bogdanos DP, et al. Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol. 2004;41:31-7.
52. Selmi C, Mayo MJ, Bach N, et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology. 2004;127:485-92.
53. Invernizzi P, Selmi C, Poli F, et al. Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology. 2008;48:1906-12.
54. Mells GF, Floyd JA, Morley KI, et al. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet. 2011;43:329-32.
55. Tanaka A, Ohira H, Kikuchi K, et al. Genetic association of Fc receptor-like 3 polymorphisms with susceptibility to primary biliary cirrhosis: ethnic comparative study in Japanese and Italian patients. Tissue Antigens. 2011;77:239-43.
56. Hirschfield GM, Liu X, Han Y, et al. Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet. 2010;42:655-7. One of the very first GWAS that identified non-HLA immunoregulatory genes as risk factors for the development of PBC.
57. Tanaka A, Invernizzi P, Ohira H, et al. Replicated association of 17q12-21 with susceptibility of primary biliary cirrhosis in a Japanese cohort. Tissue Antigens. 2011;78:65-8.
58. Liu X, Invernizzi P, Lu Y, et al. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet. 2010;42:658-60. This metanalysis of GWAS identified three new loci conferring risk to PBC.
59. Corpechot C, Chretien Y, Chazouilleres O, et al. Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis. J Hepatol. 2010;53:162-9. This epidemiological study conducted in a large cohort of French PBC patients confirmed the previously reported findings indicating that most significant infectious risk factor in PBC was a history of recurrent urinary tract infections (rUTI).
60. Gershwin ME, Selmi C, Worman HJ, et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology. 2005;42:1194-202.
61. Parikh-Patel A, Gold EB, Worman H, et al. Risk factors for primary biliary cirrhosis in a cohort of patients from the united states. Hepatology. 2001;33:16-21.
62. Prince MI, Ducker SJ, James OF. Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations. Gut. 2010;59:508-12.
63. Burroughs AK, Rosenstein IJ, Epstein O, et al. Bacteriuria and primary biliary cirrhosis. Gut. 1984;25:133-7.
64. Burroughs AK, Butler P, Sternberg MJ, et al. Molecular mimicry in liver disease. Nature. 1992;358:377-8.
65. Bogdanos DP, Baum H, Grasso A, et al. Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol. 2004;40:31-9.
66. Palermo JJ. Recurrent urinary tract infection in mice results in immune-mediated cholangiopathy similar to human primary biliary cirrhosis. Gastroenterology. 2008;134:A837.
67. Selmi C, Balkwill DL, Invernizzi P, et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology. 2003;38:1250-7.
68. Olafsson S, Gudjonsson H, Selmi C, et al. Antimitochondrial antibodies and reactivity to N. aromaticivorans proteins in Icelandic patients with primary biliary cirrhosis and their relatives. Am J Gastroenterol. 2004;99:2143-6.
69. Mattner J, Savage PB, Leung P, et al. Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe. 2008;3:304-15.
70. Mohammed JP, Fusakio ME, Rainbow DB, et al. Identification of Cd101 as a susceptibility gene for Novosphingobium aromaticivorans-induced liver autoimmunity. J Immunol. 2011;187:337-49. This study identified the genetic variants that are important for susceptibility or resistance to N. amoraticivorans-induced biliary epithelial cell destruction.
71. Koutsoumpas A, Mytilinaiou M, Polymeros D, et al. Anti-Helicobacter pylori antibody responses specific for VacA do not trigger primary biliary cirrhosis-specific antimitochondrial antibodies. Eur J Gastroenterol Hepatol. 2009;21:1220.
72. Durazzo M, Rosina F, Premoli A, et al. Lack of association between seroprevalence of Helicobacter pylori infection and primary biliary cirrhosis. World J Gastroenterol. 2004;10:3179-81.
73. Shapira Y, Agmon-Levin N, Renaudineau Y, et al. Serum markers of infections in patients with primary biliary cirrhosis: evidence of infection burden. Exp Mol Pathol. 2012. This study revealed for the first time the possible link between T.gondii and PBC.
74. Ustun S, Aksoy U, Dagci H, et al. Incidence of toxoplasmosis in patients with cirrhosis. World J Gastroenterol. 2004;10:452-4.
75. Morshed SA, Nishioka M, Saito I, et al. Increased expression of Epstein-Barr virus in primary biliary cirrhosis patients. Gastroenterol Jpn. 1992;27:751-8.
76. Barzilai O, Sherer Y, Ram M, et al. Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann N Y Acad Sci. 2007;1108:567-77.
77. Xie K, Snyder M. Two short autoepitopes on the nuclear dot antigen are similar to epitopes encoded by the Epstein-Barr virus. Proc Natl Acad Sci U S A. 1995;92:1639-43.
78. Mason A, Xu L, Shen Z, et al. Patients with primary biliary cirrhosis make anti-viral and anti-mitochondrial antibodies to mouse mammary tumor virus. Gastroenterology. 2004;127:1863-4. author reply 4-5.
79. Mason AL, Xu L, Guo L, et al. Retroviruses in autoimmune liver disease: genetic or environmental agents? Arch Immunol Ther Exp (Warsz). 1999;47:289-97.
80. Mason AL, Xu L, Guo L, et al. Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet. 1998;351:1620-4.
81. Xu L, Sakalian M, Shen Z, et al. Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis. Hepatology. 2004;39:151-6.
82. Xu L, Shen Z, Guo L, et al. Does a betaretrovirus infection trigger primary biliary cirrhosis? Proc Natl Acad Sci U S A. 2003;100:8454-9.
83. Wasilenko ST, Mason GE, Mason AL. Primary biliary cirrhosis, bacteria and molecular mimicry: what's the molecule and where's the mimic? Liver Int. 2009;29:779-82.
84. Selmi C. The evidence does not support a viral etiology for primary biliary cirrhosis. J Hepatol. 2011;54:1315-6.
85. Selmi C, Ross SR, Ansari AA, et al. Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis. Gastroenterology. 2004;127:493-501.
86. Zhang G, Chen M, Graham D, et al. Mouse mammary tumor virus in anti-mitochondrial antibody producing mouse models. J Hepatol. 2011;55:876-84. The first study to provide evidence of MMTV in a mouse experimental model of PBC.
87. Johal H, Scott GM, Jones R, et al. Mouse mammary tumour virus-like virus (MMTV-LV) is present within the liver in a wide range of hepatic disorders and unrelated to nuclear p53 expression or hepatocarcinogenesis. J Hepatol. 2009;50:548-54.
88. Mason AL, Lindor KD, Bacon BR, et al. Clinical trial: randomized controlled trial of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol. Aliment Pharmacol Ther. 2008.
89. Vergani D, Bogdanos DP, Baum H. Unusual suspects in primary biliary cirrhosis. Hepatology. 2004;39:38-41.
90. Bogdanos DP, Vergani D. Bacteria and primary biliary cirrhosis. Clin Rev Allergy Immunol. 2009;36:30-9.
91. Brahm J, Chesta J. Bacteriuria in patients with primary biliary cirrhosis. Rev Med Chil. 1993;121:499-502.
92. Floreani A, Bassendine MF, Mitchison H, et al. No specific association between primary biliary cirrhosis and bacteriuria? J Hepatol. 1989;8:201-7.
93. Liang Y, Yang Z, Zhong R. Smoking, family history and urinary tract infection are associated with primary biliary cirrhosis: a meta-analysis. Hepatol Res. 2011;41:572-8.
94. Bogdanos DP, Baum H, Butler P, et al. Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection. Dig Liver Dis. 2003;35:801-5.
95. Butler P, Hamilton-Miller J, Baum H, et al. Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis? Biochem Mol Biol Int. 1995;35:473-85.
96. Bogdanos DP, Baum H, Sharma UC, et al. Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis. J Hepatol. 2002;36:14-21.
97. Bogdanos DP, Baum H, Okamoto M, et al. Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology. 2005;42:458-65.
98. Bogdanos D, Pusl T, Rust C, et al. Primary biliary cirrhosis following Lactobacillus vaccination for recurrent vaginitis. J Hepatol. 2008;49:466-73.
99. O'Donohue J, McFarlane B, Bomford A, et al. Antibodies to atypical mycobacteria in primary biliary cirrhosis. J Hepatol. 1994;21:887-9.
100. Vilagut L, Vila J, Vinas O, et al. Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis. J Hepatol. 1994;21:673-7.
101. Vilagut L, Pares A, Vinas O, et al. Antibodies to mycobacterial 65-kD heat shock protein cross-react with the main mitochondrial antigens in patients with primary biliary cirrhosis. Eur J Clin Invest. 1997;27:667-72.
102. Bogdanos DP, Pares A, Baum H, et al. Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis. J Autoimmun. 2004;22:353-62.